Indian court investigates job exam scam that has left more than 50 dead


India's Supreme Court has ordered an investigation by the Central Bureau of Investigation (CBI) into a "multimillion-dollar college admission and government job recruitment scandal" that has left close to 50 involved dead from mysterious circumstances, The Associated Press reports. Known as the "Vyapam scam," hundreds of parents and students in Madhya Pradesh state have been arrested for paying bribes or hiring proxies to take qualifying exams for top colleges and jobs as government teachers, doctors, bankers, and policemen. More than 2,500 have been accused in connection with the scam and 1,900 of that number have been arrested, according to NPR.
Nearly 50 witnesses or participants in the scam have died over the past five years. Last week, an investigative journalist who was interviewing witnesses in Madhya Pradesh died and the next day, the dean of a medical college was found dead in a hotel room. Many of the deaths have been ruled inconclusive in autopsies, with the home minister of the state claiming the deaths are due to "natural causes," despite many of the dead being under 40.
Though the Vyapam scam dates back to at least 2007, it took until Thursday for a CBI investigation to finally be ordered by the court.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Jeva Lange was the executive editor at TheWeek.com. She formerly served as The Week's deputy editor and culture critic. She is also a contributor to Screen Slate, and her writing has appeared in The New York Daily News, The Awl, Vice, and Gothamist, among other publications. Jeva lives in New York City. Follow her on Twitter.
-
The financial changes to expect in 'Awful April'
The Explainer As the new financial year begins, it brings changes for bills, wages and tax
By Marc Shoffman, The Week UK Published
-
Crossword: April 2, 2025
The Week's daily crossword
By The Week Staff Published
-
Sudoku medium: April 2, 2025
The Week's daily medium sudoku puzzle
By The Week Staff Published
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
By Peter Weber, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published